Moderator Effect of Hypoalbuminemia in Volume Resuscitation and Plasma Expansion with Intravenous Albumin Solution.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
16 Nov 2022
Historique:
received: 31 10 2022
revised: 13 11 2022
accepted: 15 11 2022
entrez: 26 11 2022
pubmed: 27 11 2022
medline: 30 11 2022
Statut: epublish

Résumé

Intravenous administration of crystalloid or colloid solutions is the most common intervention for correcting hypovolemia in intensive care unit patients. In critical illness, especially sepsis and severe trauma, vascular wall permeability increases, and trans-endothelial escape of serum albumin, the major oncotic plasma constituent, contributes to the development of hypoalbuminemia and edema formation. The volume effects of intravenous human albumin solution exceed those of crystalloid solutions. If hypoalbuminemia is an effect moderator, the crystalloid-to-albumin ratio of fluid resuscitation volumes is not well characterized. Randomized controlled trials have confirmed that intravenous administration of human albumin solutions for volume resuscitation results in a lower net fluid balance compared with crystalloids, and smaller infusion volumes may be sufficient for hemodynamic stabilization when human albumin solutions are used. This narrative review summarizes the current evidence and conclusions drawn regarding the role of hypoalbuminemia in volume resuscitation. In the 'Saline versus Albumin Fluid Evaluation' study using 4% human albumin solution or saline, the saline-to-albumin ratio of study fluids was significantly higher in patients with baseline serum albumin concentrations of 25 g/L or less as compared to patients with baseline serum albumin concentrations of more than 25 g/L. In patients receiving renal replacement therapy, intravenous administration of 20-25% human albumin solution reduces intradialytic hypotension and improves fluid removal better than saline if serum albumin levels are similarly reduced. These data suggest that hypoalbuminemia acts as an effect moderator in volume resuscitation and plasma expansion with albumin solution. The volume effectiveness of intravenous human albumin solution in resuscitation appears to be greater when the serum albumin levels are low. In clinical situations, serum albumin concentrations per se may inform when and how to include intravenous albumin in fluid resuscitation if large amounts of crystalloids are needed, which requires further studies.

Identifiants

pubmed: 36430652
pii: ijms232214175
doi: 10.3390/ijms232214175
pmc: PMC9695189
pii:
doi:

Substances chimiques

Isotonic Solutions 0
Crystalloid Solutions 0
Serum Albumin 0
Serum Albumin, Human ZIF514RVZR

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Références

Nephrol Dial Transplant. 2022 Sep 28;:
pubmed: 36170962
N Engl J Med. 2014 Apr 10;370(15):1412-21
pubmed: 24635772
Intensive Care Med. 2011 Jan;37(1):86-96
pubmed: 20924555
Front Nutr. 2022 Jun 13;9:770674
pubmed: 35769376
J Clin Med. 2022 May 09;11(9):
pubmed: 35566786
Front Cardiovasc Med. 2022 Oct 19;9:982969
pubmed: 36337861
Crit Care Resusc. 2015 Jun;17(2):122-8
pubmed: 26017130
Intensive Care Med. 2021 Nov;47(11):1181-1247
pubmed: 34599691
Ann Intern Med. 2001 Aug 7;135(3):149-64
pubmed: 11487482
Clin J Am Soc Nephrol. 2021 May 8;16(5):820-828
pubmed: 33115729
Intensive Care Med. 2018 Nov;44(11):1797-1806
pubmed: 30343313
BMC Nephrol. 2021 Sep 8;22(1):305
pubmed: 34496793
Blood Purif. 2022;51(7):590-599
pubmed: 34515056
Crit Care Med. 1982 Oct;10(10):650-2
pubmed: 7116885
N Engl J Med. 2004 May 27;350(22):2247-56
pubmed: 15163774
J Crit Care. 2016 Oct;35:75-83
pubmed: 27481739
BMJ. 1998 Jul 25;317(7153):235-40
pubmed: 9677209
Intensive Care Med. 2022 Sep;48(9):1255-1257
pubmed: 35852553
BMJ. 2006 Nov 18;333(7577):1044
pubmed: 17040925
Crit Care. 2021 Jan 6;25(1):18
pubmed: 33407747
Med Klin Intensivmed Notfmed. 2022 Feb;117(1):69-70
pubmed: 34982191
Kidney Int. 2019 Jul;96(1):52-57
pubmed: 30926137
Arch Surg. 2004 May;139(5):552-63
pubmed: 15136357
Curr Opin Anaesthesiol. 2012 Oct;25(5):563-5
pubmed: 22825048
PLoS One. 2017 May 12;12(5):e0176292
pubmed: 28498856
J Crit Care. 2019 Apr;50:144-154
pubmed: 30540968
JAMA. 2021 Aug 10;:
pubmed: 34375394
World J Crit Care Med. 2016 Aug 04;5(3):171-9
pubmed: 27652208
Nat Rev Nephrol. 2018 Sep;14(9):541-557
pubmed: 30072710
Chin Med J (Engl). 2021 Jul 20;134(14):1639-1654
pubmed: 34397592
Curr Opin Crit Care. 2018 Dec;24(6):512-518
pubmed: 30247219
Trials. 2020 Dec 7;21(1):1002
pubmed: 33287911
Br J Anaesth. 2012 Mar;108(3):384-94
pubmed: 22290457
Intensive Care Med. 2010 Oct;36(10):1657-1665
pubmed: 20517593
Intensive Care Med. 2022 May;48(5):602-605
pubmed: 35247060
J Intensive Care. 2021 Aug 25;9(1):53
pubmed: 34433491
Crit Care Med. 2006 Oct;34(10):2536-40
pubmed: 16915107
Int J Mol Sci. 2021 Apr 26;22(9):
pubmed: 33925831
Crit Care. 2010;14(5):R185
pubmed: 20950434
J Am Soc Nephrol. 2004 Feb;15(2):487-92
pubmed: 14747397
Cochrane Database Syst Rev. 2004 Oct 18;(4):CD001208
pubmed: 15495011
N Engl J Med. 2007 Aug 30;357(9):874-84
pubmed: 17761591
Semin Dial. 2017 Nov;30(6):473-480
pubmed: 28661565
Trials. 2021 Jun 2;22(1):376
pubmed: 34078421
Blood Purif. 2018;45(4):320-326
pubmed: 29402775
Anesth Analg. 2010 Apr 1;110(4):1242; author reply 1243
pubmed: 20357164
Crit Care. 2020 May 5;24(1):191
pubmed: 32366324
Anesth Analg. 1999 May;88(5):999-1003
pubmed: 10320158
Curr Med Res Opin. 2020 Dec;36(12):1961-1973
pubmed: 33090028
J Crit Care. 2022 Apr;68:72-75
pubmed: 34929529

Auteurs

Christian J Wiedermann (CJ)

Institute of General Practice and Public Health, Claudiana-College of Health Professions, 39100 Bolzano, Italy.
Department of Public Health, Medical Decision Making and HTA, University of Health Sciences, Medical Informatics and Technology-Tyrol, 6060 Hall in Tyrol, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH